Regeneron Patent Targeted In New Post-Grant Review Petition
ALEXANDRIA, Va. — The maker of an antibody cocktail that recently won emergency use authorization for the treatment of COVID-19 is being challenged on a different front before the Patent Trial...To view the full article, register now.
Already a subscriber? Click here to view full article